Alzamend Neuro
Manufacturing · Georgia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3480 Peachtree Rd NE Fl Second Ste 103, ...Phone Number
(844) 722-6333Website
www.alzamend.comRevenue
-Stock Symbol
ALZNIndustry
About Alzamend Neuro
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company headquartered in Atlanta, Georgia, focused on developing treatments for Alzheimer’s disease, bipolar disorder, major depressive disorder, and PTSD. Its pipeline includes AL001, an ionic cocrystal therapy combining lithium, salicylate, and L-proline, and ALZN002, a cell-based therapeutic vaccine targeting beta-amyloid in Alzheimer’s disease. Alzamend is also collaborating with Massachusetts General Hospital on Phase II clinical trials evaluating AL001 for brain lithium delivery.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: ALZNShow moreAlzamend Neuro Org Chart
Compare Similar Companies to Alzamend Neuro
Compare insights from companies similar to Alzamend Neuro, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Alzamend Neuro Tech Stack
A closer look at the technologies used by Alzamend Neuro
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alzamend Neuro
Sign Up For FreeTo access detailed company insights
Alzamend Neuro, Inc. is a clinical-stage biopharmaceutical company headquartered in Atlanta, Georgia, focused on developing treatments for Alzheimer’s disease, bipolar disorder, major depressive disorder, and PTSD. Its pipeline includes AL001, an ionic cocrystal therapy combining lithium, salicylate, and L-proline, and ALZN002, a cell-based therape... Read More

